Effects of subchronic treatment with imipramine, zimelidine and alaproclate on regional tissue levels of substance P-and neurokinin a/neurokinin B-like immunoreactivity in the brain and spinal cord of the rat-Reference-Cited by-同舟云学术

Effects of subchronic treatment with imipramine, zimelidine and alaproclate on regional tissue levels of substance P-and neurokinin a/neurokinin B-like immunoreactivity in the brain and spinal cord of the rat

Published:1987-06 Issue:6 Volume:26 Page:581-590
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Brodin E.,Ögren S.O.,Theodorsson-Norheim E.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference51 articles.

1. On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5HT binding sites;Agnati;Acta physiol. scand.,1983

2. Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei;Barden;J. Neurochem.,1983

3. Further evidence for the possible coexistence of 5-hydroxytryptamine and substance P in medullary raphe neurones of rat brain;Björklund;Br. J. Pharmac.,1979

4. Characterization of two substance P antisera;Brodin;Acta physiol. scand.,1982

5. Chronic treatment with the serotonin uptake inhibitor zimelidine elevates substance P levels in rat spinal cord;Brodin;Acta physiol. scand.,1984

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets;Expert Opinion on Therapeutic Targets;2013-12-03

2. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation;Annals of the New York Academy of Sciences;2010-11-22

3. The role of substance P in stress and anxiety responses;Amino Acids;2006-07-06

4. Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers;The Journal of Clinical Pharmacology;2006-03

5. Affektive Störungen — Neurobiologie;Neurobiologie psychischer Störungen;2006